Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zulresso Home Administration for Postpartum Depression
NCT05059600Phase 4Completed
- Sponsor
- Supernus Pharmaceuticals, Inc.
- Start
- Oct 2021
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of brexanolone in postpartum depression (PPD), sponsored by Supernus Pharmaceuticals, Inc.. Started Oct 2021; status: completed.
02
Drugs
brexanolone
03
Conditions
postpartum depression (PPD)
Beyond the preview
Go deeper on NCT05059600.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05059600.